FDA Asks Drug Companies To Assess Cholesterol Drug's Cognitive Risks
Amgen, which has said it could file for regulatory approval of PCSK9 drug evolocumab this year, said it has been proactively
fda ask drug company assess cholesterol drug cognitive risks amgen say file regulatory approval pcsk drug evolocumab year say proactively